Home Depot CEO Steps Down After Medical Leave of Absence

Home Depot reported Q3 net sales of $43.4B, up 4.9%, and adjusted EPS of $3.86, beating estimates. The company raised its full-year sales growth forecast to 4.5%. CEO Ted Decker stepped down but remains chair; Ted Decker will be replaced by Ted Decker. Ann-Marie Campbell becomes president and COO, and Jordan Broggi is named finance chief.

Original reporting
Published Nov 17, 2026, 11:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 1:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Home Depot CEO Steps Down After Medical Leave of Absence — source image
Decision brief

The 30-second read

$HDNeutralMed
01

Why it matters

The combination of an earnings beat, a revised sales outlook, and a CEO/president/COO/finance leadership reshuffle creates two competing signals: fundamentals support versus execution continuity risk.

02

Market read

Traders can reassess HD’s near-term execution risk and demand outlook using the updated guidance and the leadership transition details.

03

What to watch

Traders may overweight the leadership change versus the concrete earnings beat and the raised sales growth framing, which could keep downside limited.

Relevance 7/10Novelty 6/10Timing: today, after-hours/next-session positioning around CEO transition and updated outlook

Background

The CEO change follows Ted Decker’s temporary medical leave; the company also updates full-year sales expectations alongside reporting quarterly results.

Company-level read

Ticker impact

$HDNeutralMedium confidence
Context

Home Depot reports quarterly profit and sales beats, while CEO Ted Decker steps down after a medical leave and McPhail becomes CEO.

Expected impact

Likely modest pressure or volatility as investors reprice continuity risk, partially offset by the earnings and guidance beat.

Evidence & confidence

The article contains fresh company-specific guidance and a CEO/exec reshuffle, but no explicit new operational failure or deal that would drive a large repricing by itself.

Market effects

Could marginally affect retail home-improvement peers via read-through on demand and management stability.

Primarily US large-cap retail sentiment; limited direct regional spillover.

Low, as the event is company-specific and not tied to global macro or supply shocks.

Counterpoint

Investors may view the medical-leave CEO stepdown as non-informational for fundamentals, treating it as a planned transition with minimal disruption.

Key entities

  • Home Depot

    US home-improvement retailer reporting quarterly results, updating full-year sales growth expectations, and announcing CEO/president/COO/finance leadership changes.

  • Ted Decker

    CEO who returned from medical leave, then stepped down as CEO and remains board chair.

  • McPhail

    Assumes the top role as CEO after Decker’s stepdown.

  • Ann-Marie Campbell

    Becomes president and chief operating officer after overseeing operations during Decker’s absence.

  • Jordan Broggi

    Named finance chief.

Related articles

$HDMedAI 8/10

Home Depot beats third-quarter estimates as it names new chief executive

Home Depot reported Q3 sales up 4.9% to $43.4B, beating estimates. EPS rose 3.2% to $3.86, matching forecasts. Adjusted operating income increased 2.7% to $5.66B. The company raised full-year sales growth guidance to 4.5% but expects slower Q4 comparable sales growth. Shares fell 2% premarket after announcing a new CEO, Richard McPhail, and lowering operating margin outlook to 12.8%.

$NVDAMed

Stocks making the biggest moves premarket: Disney, Home Depot, Nvidia & more

Coherent, Applied Optoelectronics, and Lumentum shares rose 11%, 8.6%, and 5.6% respectively, following a Reuters report on potential U.S. restrictions on Chinese data center equipment. Sellas Life Sciences shares gained over 7% after positive trial results for its cancer vaccine. Nvidia shares rose 1% ahead of earnings, despite a 25% stake reduction in Intel. Home Depot shares fell 2% with a CEO transition.